UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
ProShares UltraShort S&P500
SDS
$369M
| $2.91M | ﹤0.01% |
12,682
+11,841
| +1,408% | +$2.75M |
|
3002
Anavex Life Sciences
AVXL
$314M
| $2.91M | ﹤0.01% |
314,671
+266,716
| +556% | +$2.85M |
|
3003
Navient
NAVI
$796M
| $2.91M | ﹤0.01% |
176,997
+140,587
| +386% | +$2.22M |
|
|
WCLD
3004
WisdomTree Cloud Computing Fund
WCLD
$305M
| $2.91M | ﹤0.01% |
116,019
-65,937
| -36% | -$1.69M |
|
3005
Woodward
WWD
$21B
| $2.9M | ﹤0.01% |
30,066
+15,880
| +112% | +$1.47M |
|
3006
Invesco S&P SmallCap Information Technology ETF
PSCT
$508M
| $2.9M | ﹤0.01% |
72,534
+762
| +1% | +$30.7K |
|
3007
iShares Genomics Immunology and Healthcare ETF
IDNA
$208M
| $2.9M | ﹤0.01% |
115,033
-31,183
| -21% | -$838K |
|
|
AVEO
3008
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.89M | ﹤0.01% |
193,555
+191,896
| +11,567% | +$2.66M |
|
3009
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.87B
| $2.89M | ﹤0.01% |
67,337
-55,064
| -45% | -$2.35M |
|
3010
XPeng
XPEV
$11.5B
| $2.89M | ﹤0.01% |
290,443
-711,649
| -71% | -$6.41M |
|
3011
Lucid Motors
LCID
$2.6B
| $2.88M | ﹤0.01% |
42,155
+22,655
| +116% | +$2.49M |
|
3012
Equinor
EQNR
$97.4B
| $2.88M | ﹤0.01% |
80,334
-393,450
| -83% | -$14.1M |
|
3013
ICU Medical
ICUI
$4.56B
| $2.88M | ﹤0.01% |
18,264
-27,196
| -60% | -$4.14M |
|
|
ARTY
3014
iShares Future AI & Tech ETF
ARTY
$3.78B
| $2.87M | ﹤0.01% |
112,523
-6,797
| -6% | -$171K |
|
3015
CALL
Beyond Meat
BYND
$268M
| $2.87M | ﹤0.01% |
233,000
+680
| +0.3% | +$9.47K |
|
3016
PUT
Affirm
AFRM
$25.3B
| $2.87M | ﹤0.01% |
296,300
-82,100
| -22% | -$1.24M |
|
3017
Philips
PHG
$26.3B
| $2.86M | ﹤0.01% |
223,183
+180,381
| +421% | +$2.18M |
|
3018
Arcutis Biotherapeutics
ARQT
$3.26B
| $2.86M | ﹤0.01% |
193,311
+169,739
| +720% | +$2.97M |
|
3019
Allegion
ALLE
$14.1B
| $2.86M | ﹤0.01% |
27,178
-4,518
| -14% | -$471K |
|
3020
NOV
NOV
$7.38B
| $2.85M | ﹤0.01% |
136,302
+59,964
| +79% | +$1.26M |
|
|
CPE
3021
DELISTED
Callon Petroleum Company
CPE
| $2.84M | ﹤0.01% |
76,696
+5,439
| +8% | +$223K |
|
3022
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$585M
| $2.84M | ﹤0.01% |
102,173
-15,290
| -13% | -$472K |
|
3023
BlackRock Health Sciences Trust
BME
$574M
| $2.84M | ﹤0.01% |
65,127
-98,114
| -60% | -$4.17M |
|
3024
COPT Defense Properties
CDP
$4.14B
| $2.83M | ﹤0.01% |
109,209
+17,250
| +19% | +$443K |
|
|
EHAB
3025
DELISTED
Enhabit
EHAB
| $2.83M | ﹤0.01% |
215,117
+202,895
| +1,660% | +$2.71M |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.